m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT00125
|
[1], [2], [3] | |||
: m6A sites
Direct
Enhancement
RNA modification
ICAM1
ICAM1
ADAR
Methylation
: modification sites
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | Methyltransferase-like 3 (METTL3) | WRITER | |||
| m6A Target | Interferon-inducible protein 4 (ADAR1) | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | RNA modification (RNAMod) >> Adenosine-to-Inosine editing (A-to-I) | ||||
| Epigenetic Regulator | Interferon-inducible protein 4 (ADAR1) | WRITER | View Details | ||
| Regulated Target | Intercellular adhesion molecule 1 (ICAM1) | View Details | |||
| Crosstalk Relationship | m6A → A-to-I | Enhancement | |||
| Crosstalk Mechanism | m6A modification directly impacts RNA modification through modulating the expression level of RNA modification regulator | ||||
| Crosstalk Summary | METTL3 methylates Interferon-inducible protein 4 (ADAR1) mRNA, thereby enhancing its protein expression, which subsequently promotes ADAR mediated A-to-I RNA editing of the Intercellular adhesion molecule 1 (ICAM1) transcript. | ||||
| Responsed Drug | ISIS 1570 | ||||
| Pathway Response | mRNA surveillance pathway | hsa03015 | |||
| RNA degradation | hsa03018 | ||||
| Cell Process | RNA stability | ||||
In-vitro Model |
MGG8 | Glioblastoma | Homo sapiens | CVCL_D1H4 | |
| U-87MG ATCC | Glioblastoma | Homo sapiens | CVCL_0022 | ||
| U-118MG | Astrocytoma | Homo sapiens | CVCL_0633 | ||
| HUVEC-C | Normal | Homo sapiens | CVCL_2959 | ||
Full List of Potential Compound(s) Related to This m6A-centered Crosstalk
| Intercellular adhesion molecule 1 (ICAM1) | 24 Compound(s) Regulating the Target | Click to Show/Hide the Full List | ||
| ISIS 1570 | Approved | [4] | ||
| External Link | ||||
| Alicaforsen | Phase 3 | [5] | ||
| Synonyms |
Alicaforsen [INN]; ISIS 2302; ISIS-2302; Intercellular adhesion molecule-1 antisense oligodeoxynucleotide; DNA, d((R)-P-thio)(G-C-C-A-A-G-C-T-G-G-C-A-T-C-C-G-T-C-A); Deoxyribonucleic acid, d((R)-P-thio)(G-C-C-C-A-A-G-C-T-G-G-C-A-T-C-C-G-T-C-A)
Click to Show/Hide
|
|||
| External Link | ||||
| INXC-ICAM1 | Terminated | [6] | ||
| Synonyms |
Antisense ICAM-1-TCS, Inex; ICAM-1 antisense (inflammation), INEX; Transmembrane carrier system (antisense ICAM-1), Inex; Antisense (ICAM-1, inflammation), INEX
Click to Show/Hide
|
|||
| External Link | ||||
| ISIS 11159 | Investigative | [7] | ||
| External Link | ||||
| ISIS 3224 | Investigative | [7] | ||
| External Link | ||||
| ISIS 1931 | Investigative | [4] | ||
| External Link | ||||
| PIPERROLEIN B | Investigative | [8] | ||
| Synonyms |
Piperolein B; Piperoleine B; 30505-89-6; CHEMBL256214; MEGxp0_000205; SCHEMBL15471329; ACon1_000259; FAXXHNWVMKTOFF-UXBLZVDNSA-N; MCULE-4025815326; NCGC00180733-01; BRD-K04771916-001-01-8; Piperidine, 1-[(8E)-9-(1,3-benzodioxol-5-yl)-1-oxo-8-nonenyl]-; (8E)-9-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)non-8-en-1-one; Piperidine, 1-[9-[3,4-(methylenedioxy)phenyl]-8-nonenoyl]-, (E)-; (E)-9-(benzo[d][1,3]dioxol-5-yl)-1-(piperidin-1-yl)non-8-en-1-one; Piperidine, 1-[9-(1,3-benzodioxol-5-yl)-1-oxo-8-nonenyl]-, (
Click to Show/Hide
|
|||
| MOA | Inhibitor | |||
| External Link | ||||
| ISIS 2974 | Investigative | [4] | ||
| External Link | ||||
| Dehydropipernonaline | Investigative | [8] | ||
| Synonyms |
107584-38-3; Dehydropipernoline; Piperidine, 1-[9-(1,3-benzodioxol-5-yl)-1-oxo-2,4,8-nonatrienyl]-, (E,E,E)-; Piperidine, 1-(9-(1,3-benzodioxol-5-yl)-1-oxo-2,4,8-nonatrienyl)-, (E,E,E)-; AC1O5SQM; CHEMBL483708; MolPort-039-101-180; KAYVDASZRFLFRZ-PQECNABGSA-N; N-(9-(3,4-Methylenedioxyphenyl)-2,4,8-nonatrienoyl)piperidine; ZINC14658239; 9-(3,4-Methylenedioxy)-2,4,8-nonatrienoic acid piperidide; (2E,4E,8E)-9-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylnona-2,4,8-trien-1-one; Piperidine, 1-[(2E,4E,8E)-9-(1
Click to Show/Hide
|
|||
| MOA | Inhibitor | |||
| External Link | ||||
| ISIS 3067 | Investigative | [7] | ||
| External Link | ||||
| ISIS 11665 | Investigative | [7] | ||
| External Link | ||||
| PIPERNONALINE | Investigative | [8] | ||
| Synonyms |
CHEMBL450332; PKLGRWSJBLGIBF-JMQWPVDRSA-N; MolPort-006-668-470; ZINC14658236; Pipernonaline, > 9-(3,4-Methylenedioxyphenyl)-2,8-nonadienoic acid piperidide; 1-[9-(1,3-Benzodioxol-5-yl)-1-oxo-2,8-nonadienyl]piperidine, 9CI; (2E,8E)-9-(benzo[d][1,3]dioxol-5-yl)-1-(piperidin-1-yl)nona-2,8-dien-1-one; (2E,8E)-9-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)nona-2,8-dien-1-one
Click to Show/Hide
|
|||
| MOA | Inhibitor | |||
| External Link | ||||
| ISIS 11158 | Investigative | [7] | ||
| External Link | ||||
| Pellitorin | Investigative | [8] | ||
| Synonyms |
Pellitorine; 18836-52-7; trans-Pellitorin; (E,E)-N-(2-Methylpropyl)-2,4-decadienamide; (E,E)-N-Isobutyl-2,4-decadienamide; N-Isobutyldeca-trans-2,trans-4-dienamide; UNII-8IS5231171; 2,4-DECADIENAMIDE, N-ISOBUTYL-, (E,E)-; 2,4-Decadienamide, N-(2-methylpropyl)-, (E,E)-; BRN 1725967; AI3-19560; CHEBI:69686; MAGQQZHFHJDIRE-BNFZFUHLSA-N; Pellitorine (6CI); 2,4-Decadienamide, N-(2-methylpropyl)-, (2E,4E)-; 8IS5231171; (2E,4E)-N-(2-methylpropyl)deca-2,4-dienamide; N-(2-Methylpropyl)-2,4-Decadienamide; Optaflow A
Click to Show/Hide
|
|||
| MOA | Inhibitor | |||
| External Link | ||||
| A-286982 | Investigative | [9] | ||
| Synonyms |
280749-17-9; UNII-5I8WFS075A; A 286982; CHEMBL19677; 5I8WFS075A; C24H27N3O4S; (2E)-1-(4-Acetyl-1-piperazinyl)-3-[4-[[2-(1-methylethyl)phenyl]thio]-3-nitrophenyl]-2-propen-1-one; SCHEMBL5829786; GTPL6592; SCHEMBL12063498; AOB1772; SYN5060; MolPort-023-277-110; ZINC602716; BDBM50092956; AKOS024458044; API0010263; Piperazine, 1-acetyl-4-((2E)-3-(4-((2-(1-methylethyl)phenyl)thio)-3-nitrophenyl)-1-oxo-2-propenyl)-; (E)-1-(4-acetylpiperazin-1-yl)-3-[3-nitro-4-(2-propan-2-ylphenyl)sulfanylphenyl]prop-2-en-1-one; AS-16426
Click to Show/Hide
|
|||
| MOA | Inhibitor | |||
| External Link | ||||
| lifitegrast | Approved | [10] | ||
| Synonyms |
Xiidra; 1025967-78-5; SAR-1118; SAR 1118; UNII-038E5L962W; CHEMBL2048028; 038E5L962W; (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoic acid; (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoic acid;(S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoic acid; SAR-1119; SHP606; SPD606
Click to Show/Hide
|
|||
| External Link | ||||
| Alicaforsen | Phase 3 | [5] | ||
| Synonyms |
Alicaforsen [INN]; ISIS 2302; ISIS-2302; Intercellular adhesion molecule-1 antisense oligodeoxynucleotide; DNA, d((R)-P-thio)(G-C-C-A-A-G-C-T-G-G-C-A-T-C-C-G-T-C-A); Deoxyribonucleic acid, d((R)-P-thio)(G-C-C-C-A-A-G-C-T-G-G-C-A-T-C-C-G-T-C-A)
Click to Show/Hide
|
|||
| External Link | ||||
| APC-8015F | Phase 2 | [10] | ||
| Synonyms |
CD54-postive autologous cell immunotherapy (hormone refractory prostate cancer), Dendreon
Click to Show/Hide
|
|||
| External Link | ||||
| BI-505 | Phase 2 | [10] | ||
| External Link | ||||
| AIC100 | Phase 1 | [10] | ||
| External Link | ||||
| A-252444.0 | Terminated | [10] | ||
| Synonyms |
A-155918; A-205804; A-241548
Click to Show/Hide
|
|||
| External Link | ||||
| MOR-102 | Terminated | [10] | ||
| Synonyms |
MOR-101; MOR-101); ICAM-1 antibody (inflammation), MorphoSys
Click to Show/Hide
|
|||
| External Link | ||||
| GI-270384X | Terminated | [10] | ||
| External Link | ||||
| ISIS-1939 | Investigative | [10] | ||
| Synonyms |
136216-59-6
Click to Show/Hide
|
|||
| External Link | ||||
References
: m6A sites
: modification sites